Author Archives: Priscille Rivière

An artificial intelligence predicts therapeutic response in patients with advanced rectal cancer treated with preoperative radiochemotherapy

The digestive oncology teams from European Georges Pompidou Hospital, Cochin and Ambroise Paré AP-HP, and laboratory “Information Sciences and personalized medicine” of 1138 Unit Research Center Cordeliers INSERM and Paris-Descartes University, have developed an artificial intelligence system that predict therapeutic response to preoperative chemoradiotherapy in patients monitored for rectal cancer. The work, coordinated by Dr. Jean-Emmanuel Bibault of oncology radiotherapy European Hospital Georges Pompidou AP-HP, would propose a conservative treatment rather than full rectal ablation patients complete therapeutic response.

Posted in Cancer, Press releases, Circulation, metabolism, nutrition | Tagged | Comments closed

Thursday 30 August 2018

Posted in Synthèse de presse | Comments closed

Metformin Improves Motor Skills in Patients with Steinert Myotonic Dystrophy, the Most Common Adult Neuromuscular Disease

Inserm researchers at I-Stem – the Institute for Stem Cell Therapy and Exploration of Monogenic Diseases – report encouraging results with metformin, a known diabetes drug, for the symptomatic treatment of Steinert myotonic dystrophy. A phase II trial conducted in 40 patients at Henri-Mondor Hospital AP-HP has shown that, after 48 weeks of treatment at the highest dose, patients treated with metformin (versus placebo) gain in motor skills and recover a more stable gait. The results of this trial, which received 1.5 million euros in funding from AFM-Téléthon, are published today in Brain.

Posted in Press releases, Neurosciences, cognitives sciences, neurology and psychiatry | Tagged | Comments closed

Wednesday 29 August 2018

Posted in Synthèse de presse | Comments closed

Tuesday 28 August 2018

Posted in Synthèse de presse | Comments closed

Predicting The Response To Immunotherapy Using Artificial Intelligence

A study published in The Lancet Oncology establishes for the first time that artificial intelligence can process medical images to extract biological and clinical information. By designing an algorithm and developing it to analyse CT scan images, medical researchers at Gustave Roussy, CentraleSupélec, Inserm, Paris-Sud University and TheraPanacea (spin-off from CentraleSupélec specialising in artificial intelligence in oncology-radiotherapy and precision medicine) have created a so-called radiomic signature. This signature defines the level of lymphocyte infiltration of a tumour and provides a predictive score for the efficacy of immunotherapy in the patient.     

Posted in Cancer, Press releases, Health technologies | Tagged | Comments closed

Mechanism of Repression: Can a Person’s Memories be Altered Without Their Knowledge?

In recent years, the cognitive neurosciences have shown that it is possible to use conscious effort to alter memories. Researchers from the Inserm Center for Psychiatry and Neuroscience, Sainte Anne Hospital and Université Paris Descartes now show that it is possible to unconsciously alter memories. This experimental demonstration of the unconscious manipulation of memories, which is similar to the psychoanalytical concept of repression, has been published in the journal Cognition.

Posted in Neurosciences, cognitives sciences, neurology and psychiatry | Tagged | Comments closed

Monday 27 August 2018

Posted in Synthèse de presse | Comments closed

Wednesday 24 August 2018

Posted in Synthèse de presse | Comments closed

Tuesday 22 August 2018

Posted in Synthèse de presse | Comments closed
fermer
fermer
RSS Youtube